Anzeige

2008: 99/5 (May) pp. 799-983

Journal:Thrombosis and Haemostasis
ISSN:0340-6245

Archive
Issue

34 articles
1.
Propagating factor IX-producing hepatocytes for haemophilia B therapy

Frederick A. Ofosu

Canadian Blood Services and Department of Pathology & Molecular Medicine, McMaster University, Hamilton, Ontario, Canada

Thrombosis and Haemostasis 2008 99 5: 799-800

http://dx.doi.org/10.1160/TH08-04-0200

[Summary] [Free download]
2.
Thromboembolic complications of sepsis: What is the incidence and pathophysiological mechanisms involved?

Michal Holub

3rd Department of Infectious and Tropical Diseases, First Faculty of Medicine, Charles University in Prague, Czech Republic

Thrombosis and Haemostasis 2008 99 5: 801-802

http://dx.doi.org/10.1160/TH08-03-0192

[Summary] [Free download]
3.
Therapeutic integrin inhibition: Allosteric and activation-specific inhibition strategies may surpass the initial ligand-mimetic strategies

Ingo Ahrens, Karlheinz Peter

Baker Heart Research Institute, Melbourne, Australia

Thrombosis and Haemostasis 2008 99 5: 803-804

http://dx.doi.org/10.1160/TH08-03-0194

[Summary] [Free download]
4.
Current use of biologicals in thrombosis and haemostasis

Frederick A. Ofosu1,2, Trevor W. Barrowcliffe3

1Canadian Blood Services and 2McMaster University, Hamilton, Ontario, Canada; 33 Boulby Bank, Whitby, UK

Thrombosis and Haemostasis 2008 99 5: 805-806

http://dx.doi.org/10.1160/TH08-04-0201

[Summary] [Free download]
5.
Heparin and low-molecular-weight heparin

Elaine Gray1, Barbara Mulloy1, Trevor W. Barrowcliffe1,2

1National Institute for Biological Standards & Control, Potters Bar, UK; 2Current address: 3 Boulby Bank, Whitby, UK

Thrombosis and Haemostasis 2008 99 5: 807-818

http://dx.doi.org/10.1160/TH08-01-0032

[Summary] [Free download]
6.
The direct thrombin inhibitor hirudin

Andreas Greinacher1, Theodore E. Warkentin2

1Institut für Immunologie und Transfusionsmedizin, Ernst-Moritz-Arndt Universität Greifswald, Greifswald, Germany; 2Department of Pathology and Molecular Medicine, and Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada

Thrombosis and Haemostasis 2008 99 5: 819-829

http://dx.doi.org/10.1160/TH07-11-0693

[Summary] [Free download]
7.
Bivalirudin

Theodore E. Warkentin1, Andreas Greinacher2, Andreas Koster3

1Department of Pathology and Molecular Medicine, and Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada; 2Department of Immunology and Transfusion Medicine, Ernst-Moritz-Arndt-University Greifswald, Greifswald, Germany; 3Department of Anesthesia, Deutsches Herzzentrum Berlin, Berlin, Germany

Thrombosis and Haemostasis 2008 99 5: 830-839

http://dx.doi.org/10.1160/TH07-10-0644

[Summary] [Free download]
8.
Recombinant clotting factors

Steven W. Pipe

Recombinant, factor VIII, factor IX, factor VIIa, von Willebrand factor

Thrombosis and Haemostasis 2008 99 5: 840-850

http://dx.doi.org/10.1160/TH07-10-0593

[Summary] [Free download]
9.
Plasma-derived biological medicines used to promote haemostasis

Frederick A. Ofosu1, John Freedman2, John W. Semple2

1Canadian Blood Services and Department of Pathology & Molecular Medicine, McMaster University, Hamilton, Ontario, Canada; 2Department of Laboratory Medicine, St. Michael’s Hospital, University of Toronto, Toronto, Ontario, Canada

Thrombosis and Haemostasis 2008 99 5: 851-862

http://dx.doi.org/10.1160/TH07-10-0592

[Summary] [Free download]
10.
Haematopoietic growth factors and their therapeutic use

Meenu Wadhwa, Robin Thorpe

Biotherapeutics Group, National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Potters Bar, Hertfordshire, United Kingdom

Thrombosis and Haemostasis 2008 99 5: 863-873

http://dx.doi.org/10.1160/TH07-11-0703

[Summary] [Free download]
11.
Factors that contribute to the immmunogenicity of therapeutic recombinant human proteins

Ilya Mukovozov1, Thomas Sabljic1, Gonzalo Hortelano1-3, Frederick A. Ofosu1,2

1Department of Pathology & Molecular Medicine, McMaster University, Hamilton, Ontario, Canada; 2Canadian Blood Services and Department of Pathology & Molecular Medicine, McMaster University, Hamilton, Ontario, Canada; 3School of Bioengineering, McMaster University, Hamilton, Ontario, Canada

Thrombosis and Haemostasis 2008 99 5: 874-882

http://dx.doi.org/10.1160/TH07-11-0654

[Summary] [Free download]
12.
[Add to basket]
Successful in vivo propagation of factor IX-producing hepatocytes in mice: Potential for cell-based therapy in haemophilia B

Kohei Tatsumi1, Kazuo Ohashi2, 5, Miho Kataoka3, Chise Tateno3, #, Masaru Shibata1, Hiroyuki Naka1, Midori Shima1, Michiyoshi Hisanaga2, Hiromichi Kanehiro2, Teruo Okano5, Katsutoshi Yoshizato3, 4, #, Yoshiyuki Nakajima2, Akira Yoshioka1

1Department of Pediatrics, Nara Medical University, Nara, Japan; 2Department of Surgery, Nara Medical University, Nara, Japan; 3Yoshizato Project, Cooperative Link of Unique Science and Technology for Economy Revitalization (CLUSTER), Hiroshima Prefectural Institute of Industrial Science and Technology, Hiroshima, Japan; 4Graduate School of Science, Hiroshima University, Hiroshima, Japan; 5Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University, Tokyo, Japan

Thrombosis and Haemostasis 2008 99 5: 883-891

http://dx.doi.org/10.1160/TH07-09-0559

[Summary] [PDF] [Pay per view]
13.
[Add to basket]
Venous and arterial thromboembolism in severe sepsis

Robert L. Levine1, Jacques R. LeClerc2, Joan E. Bailey3, Matthew J. Monberg4, Samiha Sarwat5

1Department of Neurosurgery, University of Texas School of Medicine at Houston, Houston, Texas, USA; 2Retired employee and current shareholder/beneficiary of Eli Lilly & Co., 2404 Sunny Slope, Bridgewater, New Jersey, USA; 3Eli Lilly and Company, Lilly Corporate Center, Drop Code 6072, Indianapolis, Indiana, USA; 4Eli Lilly and Company, Drop Code 6831, Indianapolis, Indiana, USA; 5Eli Lilly and Company, Lilly Corporate Center, Drop Code 6025, Indianapolis, Indiana, USA

Thrombosis and Haemostasis 2008 99 5: 892-898

http://dx.doi.org/10.1160/TH08-01-0004

[Summary] [PDF] [Pay per view]
14.
[Add to basket]
P-selectin gene haplotypes modulate soluble P-selectin concentrations and contribute to the risk of venous thromboembolism

Cihan Ay1,*, Lea V. Jungbauer2,*, Alexandra Kaider3, Silvia Koder1, Simon Panzer4, Ingrid Pabinger1, Christine Mannhalter2

1Division of Haematology and Haemostaseology, Department of Internal Medicine I, 2Clinical Institute of Medical and Chemical Laboratory Diagnostics, 3Core Unit for Medical Statistics and Informatics, Section of Clinical Biometrics, 4Clinic for Blood Group Serology; all Medical University Vienna, Vienna, Austria

Thrombosis and Haemostasis 2008 99 5: 899-904

http://dx.doi.org/10.1160/TH07-11-0672

[Summary] [PDF] [Pay per view]
15.
[Add to basket]
Association of ADAMDEC1 haplotype with high factor VIII levels in venous thromboembolism

Mario Berger12*, Henriette Moscatelli1*, Bettina Kulle3, Beate Luxembourg4, Katja Blouin12, Michael Spannagl5, Edelgard Lindhoff-Last4, Christian M. Schambeck6

1Medical Department and 2Institute of Clinical Biochemistry and Pathobiochemistry – Central Laboratory, University of Würzburg, Würzburg, Germany; 3Department of Biostatistics and Department of Mathematics, University of Oslo, Oslo, Norway; 4Medical Department, University of Frankfurt, Frankfurt, Germany; 5Medical Department, University of Munich, Munich, Germany; 6Institute of Clinical Chemistry – Campus Kiel, University Hospital Schleswig-Holstein, Kiel, Germany

Thrombosis and Haemostasis 2008 99 5: 905-908

http://dx.doi.org/10.1160/TH08-01-0059

[Summary] [PDF] [Pay per view]
16.
[Add to basket]
Microparticle-associated vascular adhesion molecule-1 and tissue factor follow a circadian rhythm in healthy human subjects

Leigh A. Madden1, Rebecca V. Vince1, Marie E. Sandström2, Lee Taylor2, Lars McNaughton2, Gerard Laden3

1Postgraduate Medical Institute, University of Hull, Hull, UK; 2Department of Sport, Health and Exercise Science, University of Hull, Hull, UK; 3Hyperbaric Unit, Hull and East Riding Hospital, Anlaby, Hull, UK

Thrombosis and Haemostasis 2008 99 5: 909-915

http://dx.doi.org/10.1160TH008-01-0030

[Summary] [PDF] [Pay per view]
17.
[Add to basket]
Survival of von Willebrand factor released following DDAVP in a type 1 von Willebrand disease cohort: Influence of glycosylation, proteolysis and gene mutations

Carolyn M. Millar1, Anne F. Riddell1, Simon A. Brown1, Richard Starke2, Ian Mackie2, Derrick J. Bowen3, P. Vincent Jenkins1, Jan A. van Mourik4

1Katharine Dormandy Haemophilia Centre and Thrombosis Unit, University College and Royal Free Medical School, London, UK; 2Haemostasis Research Unit, University College London, London, UK; 3Department of Haematology, School of Medicine, Cardiff University, Cardiff, UK; 4Department of Plasma Proteins, Sanquin Research, Amsterdam and Department of Vascular Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands

Thrombosis and Haemostasis 2008 99 5: 916-924

http://dx.doi.org/10.1160/TH07-09-0565

[Summary] [PDF] [Pay per view]
18.
[Add to basket]
The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors - Case-control study and meta-analysis

Matus Rehak1,2, Jiri Rehak2, Marc Müller3, Susanne Faude1, Frank Faude1, Annelie Siegemund4, Vera Krcova5, Ludek Slavik5, Dirk Hasenclever6, Markus Scholz6, Peter Wiedemann1

1Department of Ophthalmology, University Hospital Leipzig, Leipzig, Germany; 2Department of Ophthalmology, University Hospital Olomouc, Olomouc, Czech Republic; 3Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Leipzig, Germany; 4Intensive Care Unit, University Hospital Leipzig, Leipzig, Germany; 5Department of Haematology and Oncology, University Hospital Olomouc, Olomouc, Czech Republic; 6Institute for Medical Informatics, Statistics and Epidemiology (IMISE), University of Leipzig, Leipzig, Germany

Thrombosis and Haemostasis 2008 99 5: 925-929

http://dx.doi.org/10.1160/TH07-11-0658

[Summary] [PDF] [Pay per view]
19.
[Add to basket]
Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy

Francesca Cesari1, Rossella Marcucci1, Roberto Caporale2, Rita Paniccia1, Eloisa Romano1, Gian Franco Gensini3, Rosanna Abbate1, Anna Maria Gori1

1Department of Medical and Surgical Critical Care, Thrombosis Centre; Center for the Study at Molecular and Clinical Level of Chronic, Degenerative and Neoplastic Diseases to Develop Novel Therapies, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy; 2Central Laboratory, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy; 3Centro S. Maria agli Ulivi, Fondazione Don Carlo Gnocchi Onlus IRCCS, Impruneta, Florence, Italy

Thrombosis and Haemostasis 2008 99 5: 930-935

http://dx.doi.org/10.1160/TH08-01-0002

[Summary] [PDF] [Pay per view]
20.
[Add to basket]
Crosstalk between coagulation and inflammation during Dengue virus infection

Alejandra Huerta-Zepeda1, Carlos Cabello-Gutiérrez1, Jorge Cime-Castillo1, Verónica Monroy-Martínez1, Maria Eugenia Manjarrez-Zavala2, Margarita Gutiérrez-Rodríguez3, Raúl Izaguirre4, Blanca H. Ruiz-Ordaz1

1Departamento de Biología Molecular y Biotecnología. Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, UNAM, México D.F., Mexico; 2Departamento de Virología, Instituto Nacional de Enfermedades Respiratorias, México D.F., México; 3Departamento de Bioquímica, Hospital de Especialidades, Centro Médico Siglo XXI, IMSS, México D.F., México; 4Departamento de Hematología, Hospital de Cardiología “Ignacio Chávez” SSA, México D.F., México

Thrombosis and Haemostasis 2008 99 5: 936-943

http://dx.doi.org/10.1160/TH07-08-0483

[Summary] [PDF] [Pay per view]
  1-20 21-34
Next page

Articles

You've 98 Article(s) in your Basket.

Thrombosis News

TH107.2

With the expiry or pending expiry of originator low-molecular-weight heparin (LMWH) patents,...

TH 107.1

T&H has a new type of article! Read the first T&H Insights article by Lutgens et al. in the...

TH 106.6

Read the important position document from the European Heart Rhythm Association [EHRA] and the...